Christopher B. Jones, MD Make an Appointment Ask a Question Refer Patient Christopher B. Jones, MD is a medical oncologist and hematologist in Golden, Colorado. Dr. Jones is a member of the Division of Oncology and Department of Medicine at National Jewish Health. Department of Medicine Western Hematology-Oncology Division of Oncology 5280 Top Doctors 2020 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2019-2020 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2020 — Castle Connolly Medical, Ltd. Email Profile Print Profile Overview Contact Info & Locations Patient Ratings & Comments Programs & Services Cancer Care Department of Medicine Division of Oncology Specialties & Conditions All forms of Cancer Hematologic Diseases Lung Cancer Lung Metastases Lung Nodules Mesothelioma Pleural Effusion Research Areas Medical Oncology Special Interests I am a clinical hematology/oncology physician. I see all types of hematologic disorders and every type of cancer. I am interested in cooperative group oncology clinical trials to promote best practice in oncology to achieve optimal results. Education Education 1997 University of Miami School of Medicine, Miami, FL, Residency 2000 Tripler Army Medical Center, Tripler, HI, Internal Medicine Fellowship 2003 Brooke Army Medical Center, Ft. Sam Houston, TX, Hematology/Oncology Awards & Recognition 2005-2006: UTHSCA Outstanding Faculty Award for 3rd year Medical Student 2005: Bronze Star, Operation Iraqi Freedom II 2000: William J Uphouse Award for most compassionate physician Board Certification 2003: Medical Oncology 2003: Hematology 2000: Internal Medicine Professional Memberships ASCO American Society Hematology Publications Schwartz Garry H and Jones Christopher B. et al. A Phase I and Pharmacokinetic Study of Non-polyglutamatible Thymidylate Synthase Inhibitor ZD9331 and Docetaxel in Patients with Advanced Solid Malignancies. Investigational New Drugs 22: 437-448, 2004. Mita AC, Hammond LA, Jones CB et al. Phase I and Pharmacokinetic Study of Tasidotin Hydrochloride (ILX651), a Third Generation Dolastatin-15 Analogue, Administered Weekly for 3 Weeks Every 28 Days in Patients with Advanced Solid Tumors. Clinical Cancer Research. 12: 5207-5215, 2006. R.F. Setlik, G. Preston, C.B Jones et al. A Phase I Study of the Effects of Hepatic Impairment on the Pharmacokinetic (PK) and Safety of Satraplatin in Patients with Refractory Non-Hematologic Cancer. ASCO Clinical Proceedings, Abstract #2045, 2006 Shumway NM, Jones CB, and Terrazzino S. Randomized pilot study comparing aprepitant to olanzapine for treatment of chemotherapy-induced nausea and vomiting. ASCO Clinical Proceedings, Abstract 9633, 2009 Teaching & Professional Positions 2013-2015: Levine Cancer Institute, Leukemia Committee 2013-2015: Levine Cancer Institute, Upper/Lower GI Cancer Committee 2013-2015: Levine Cancer Institute, Genetic Committee 2007-2008: Chief, Hematology/Oncology Services, Brooke Army Medical Center 2006-2008: Assistant Program Director, SAUSWEC Hematology/Oncology Fellowship 2004-2005: Chief Medical Services, 115th Field Hospital Languages Spanish, Italian Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 303.650.4042 or 303.232.0602Fax: 303.650.4046 or 303.988.8750Alternate: 877.225.5654 Locations Western Hematology Oncology 400 Indiana Street Red Rocks Medical Center #230 Golden, CO 80401 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.